Explore 3 Stock Ideas & Industry Insights Download Free Report

small-cap

NAN Delivers Revenue Growth Through Trophon Expansion and Installed Base Growth

Aug 25, 2026 | Team Kalkine
NAN Delivers Revenue Growth Through Trophon Expansion and Installed Base Growth
Image source: shutterstock

  • NAN:ASX
  • Investment Type
    Small-Cap
  • Risk Level
  • Action
  • Rec. Price (AU$)

Company Overview: Nanosonics Limited (ASX: NAN) is an infection prevention company engaged in the manufacturing and distribution of ultrasound probe disinfectors and associated consumables and accessories. The company is focused on the research, development and commercialisation of infection control and decontamination products and related technologies. Kalkine’s Daily Report covers the Key Financial Metrics, Risks, Outlook, Technical Analysis along with the Valuation, Target Price, and Recommendation on the stock.

Section 1.0: Key Metrics in Pictures


Disclaimer-

Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions  and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.

Past performance is not a reliable indicator of future performance.

Support

Hi! How can we help you today?

Loading…